Navigation Links
Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
Date:10/11/2007

Sagent to Accelerate Anesiva's Penetration of the Hospital Market with

Zingo

SOUTH SAN FRANCISCO, Calif. and SCHAUMBURG, Ill., Oct. 11 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) and Sagent Pharmaceuticals, Inc., today announced an agreement in which Sagent will co-promote for three years Anesiva's Zingo(TM) (lidocaine hydrochloride monohydrate) powder intradermal injection product and will manage U.S. distribution. Zingo, a needle-free product that provides fast-acting topical, local analgesia, has been recently approved by the U.S. Food and Drug Administration (FDA) to reduce the pain associated with venous access procedures, such as IV insertions or blood draws, in children three to 18 years of age.

Under the agreement, Sagent will join with Anesiva to co-promote Zingo within hospitals as well as facilitating contract negotiations with hospitals and group purchasing organizations. Sagent's team will focus their selling efforts toward hospital pharmacists, with Anesiva promoting primarily to physicians and nurses. In addition, Sagent will manage Zingo warehousing and distribution services. The terms of the agreement provide for Sagent to earn a royalty based on Anesiva's net sales of Zingo and for Anesiva to reimburse Sagent for certain direct expenses. Anesiva may designate additional marketing partners to address non-hospital affiliated markets.

"We are very excited to work with their extremely seasoned sales and national accounts team to support Zingo's penetration of the hospital market," said John P. McLaughlin, chief executive officer of Anesiva. "Together with Anesiva's experienced marketing organization and planned sales force of 15 representa
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. JT Packard exec resigns after settling copyright disputes
2. Cray signs $250M deal to develop supercomputer
3. Donley resigns as WiCell director
4. WARF signs licensing pact with BD Biosciences
5. TeraMedica signs agreement with ThedaCare
6. CATI signs agreement for food processing technology
7. Doyle signs bill that impacts electronic medical records
8. Doyle signs "self-dealing" bill
9. Electronic signs for municipalities: Las Vegas or lost revenues?
10. NorthStar signs exclusive agreement with Illinois foundation
11. Renaissance Learning CEO resigns to start company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... This webinar will focus on EMA ... assessment in biosimilars. , Regulatory frameworks are evolving many ... however the complex nature of biopharmaceuticals makes the demonstration ... extremely challenging. Based on the specific aspects of biosimilar ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how latent viruses ... is the Epstein Barr Virus (EBV), and one of these ... chronic inflammatory disease that destroys the body’s joints. As predicted ... high concentrations of EBV DNA in their bodies (1). ...
(Date:1/15/2014)... 2014 AudioNotch is the internet's leading ... the treatment of tinnitus. Patients listen to sound therapy ... a period of weeks to months, their tinnitus volume decreases. ... forms: Notched Music and Notched White Noise. Now, AudioNotch is ...
(Date:1/14/2014)... CA (PRWEB) January 14, 2014 Histogen, ... the products of cells grown under simulated embryonic conditions, ... license agreement with Suneva Medical, Inc. for physician-dispensed aesthetic ... , This agreement is an amendment to ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... Computers might one day recycle part of their own waste ... State University. The material is a semiconductor called gallium ... Materials , researchers describe the detection of an effect that ... spin in a semiconductor. Once developed, the effect ...
... 2010 ... ... var shortURL = ""; ... we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; ...
... Call to Discuss Results for Fourth Quarter Fiscal 2010 -- LAIYANG, China, Sept. 27 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are ...
Cached Biology Technology:Semiconductor could turn heat into computing power 2Semiconductor could turn heat into computing power 3Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 2Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 3Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 4Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 5Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 6Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 7Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 8Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company 9Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 2Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 3Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 4Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 5Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 6Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010 7
(Date:4/24/2014)... or a stop sign? Or have you heard someone ... totally missed seeing? , "When we have different things ... of so much of what we see," said Kyle ... Illinois. "For example, when you,re driving, you might really ... there,s an unexpected event: an emergency vehicle, a pedestrian, ...
(Date:4/24/2014)... COLUMBIA, Mo. When bacteria attack plants, they ... cells to weaken and suppress natural defenses. However, ... the plant cells as a potential host. Now, ... and replicated the process that allows the bacteriaknown ... discovery could lead to natural anti-infective treatments that ...
(Date:4/24/2014)... New research led by Alison Allan, PhD, a scientist ... shows why breast cancer often spreads or metastasizes to ... diagnosed cancer and the number two cause of cancer-related ... early, traditional chemotherapy and radiation have a high success ... many conventional treatments fail. In particular, the lung is ...
Breaking Biology News(10 mins):Controlling brain waves to improve vision 2Controlling brain waves to improve vision 3Plants send out signals attracting harmful bacteria, MU study finds 2New study helps to explain why breast cancer often spreads to the lung 2
... a significant step forward in understanding the causes of some forms ... 7 motor protein - found in the tiny hairs of the ... a different way from many other myosins. , Dr ... says: "We,re really excited by this discovery as it could lead ...
... Oncology (ESMO), the European Society for Therapeutic Radiology ... Surgeons (ESTS) and the European Respiratory Society (ERS) ... Conference on Thoracic Oncology (EMCTO). This meeting ... perspective of state-of-the-art on the prevention, screening, ...
... SPRING HARBOR, N.Y. (Tues., March 3, 2009) ... proteins in cells are featured in the March issue ... ). Thomas J. Wandless and colleagues from Stanford ... Protein Stability in Mammalian Cells Using Small Molecules." This ...
Cached Biology News:Study offers clues to beating hearing loss 2European Multidisciplinary Conference on Thoracic Oncology 2European Multidisciplinary Conference on Thoracic Oncology 3Protein function and chromatin structure methods featured in Cold Spring Harbor Protocols 2
Template and primers for preparation of internal control spots...
Biotin-OSu is used to label proteins, immunological agents, DNA and synthetic oligonucleotides. Biotin labeling is detected through enzymatically labeled avidin or streptavidin proteins that conforma...
Reusble. Uses in conjunction with the Apoptotic Cell Isolation Kit....
RAT ANTI MOUSE JAM-2 Immunogen: Recombinant soluble JAM-2...
Biology Products: